Page last updated: 2024-08-23

selegiline and Encephalopathy, Toxic

selegiline has been researched along with Encephalopathy, Toxic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurlan, R1
Jyoti, A; Sethi, P; Sharma, D1
Ebadi, M; Muralikrishnan, D1

Other Studies

3 other study(ies) available for selegiline and Encephalopathy, Toxic

ArticleYear
"Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.
    Neurology, 2005, Mar-08, Volume: 64, Issue:5

    Topics: Aged; Amantadine; Benzothiazoles; Catechols; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Iatrogenic Disease; Indoles; Levodopa; Male; Middle Aged; Neurology; Neuropharmacology; Neurotoxicity Syndromes; Nitriles; Parkinson Disease; Pramipexole; Selegiline; Thiazoles; Treatment Outcome

2005
Bacopa monniera prevents from aluminium neurotoxicity in the cerebral cortex of rat brain.
    Journal of ethnopharmacology, 2007, Apr-20, Volume: 111, Issue:1

    Topics: Aldehydes; Aluminum Chloride; Aluminum Compounds; Animals; Antioxidants; Bacopa; Cerebral Cortex; Chlorides; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Glutathione Transferase; India; Lipid Peroxidation; Male; Medicine, Ayurvedic; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Plant Extracts; Protein Carbonylation; Rats; Rats, Wistar; Selegiline; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances

2007
SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Brain research, 2001, Feb-23, Volume: 892, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antioxidants; Catalase; Dopamine Agents; Dopamine Agonists; Glutathione; Mice; Mice, Inbred BALB C; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neostriatum; Nerve Tissue Proteins; Neurotoxicity Syndromes; Selegiline; Superoxide Dismutase

2001